Mayur Parmar

🎉 Excited to share our latest review article, “Gene therapy for Parkinson’s disease: current landscape, translational challenges, and future directions,” published in Expert Review of Neurotherapeutics #GeneTherapy #ParkinsonsDisease #Neurotherapeutics tandfonline.com/doi/full/10.10…

Celiac disease is more than an autoimmune enteropathy. This review in #SNCCM explores the hidden economic, psychological, and societal CD costs, emphasising the role of diagnostic delays, comorbidities, work loss, and the true price of a gluten-free diet. link.springer.com/article/10.100…

I am excited to share my research is now published! 📚 Targeting neuroinflammation in neurodegenerative disorders: the emerging potential of semaglutide link.springer.com/article/10.100… #Semaglutide #Neuroinflammation @SN

Excited to share my research highlights for 2025! Check out this personalised summary of my Springer Nature publications and the impact of my research in 2025. yir.sn.pub/MGf3th #SNAuthors #YiR2025

🧠 Bridging the gap in Alzheimer’s research: Resveratrol (RSV) shows promise, but clinical translation remains a challenge. This schematic highlights 3 key strategies to overcome RSV’s poor bioavailability & rapid metabolism - 📃🔗link.springer.com/article/10.100…

Balancing Caution and Exploration in Ivermectin’s Use for Cancer. Key principles for healthcare providers to manage patient inquiries, combat misinformation, and support evidence-based research. link.springer.com/article/10.100…

Prasinezumab (anti-alpha-synuclein antibody) is moving forward into a phase 3 clinical study to test the potential for slowing (delaying) progression of Parkinson's! roche.com/media/releases…

Note: Wegovy was first FDA-approved for obesity treatment in June 2021.

📢 New Development: Wegovy (Semaglutide), a GLP-1 agonist initially developed for type 2 diabetes. 🚨 FDA Approval: The U.S. FDA has approved Novo Nordisk’s weight-loss drug, Wegovy, for reducing ❤️ heart risks in overweight or obese adults without diabetes. #semaglutide

This year, the FOMA Student Awards will be presented on February 17, 2024 at the FOMA Live Convention. This year, the winners from NSU-KPCOM Tampa Bay are: - Matthew Green - Jason Nguyen Congratulations to our winners, we cannot wait to see what the future holds for you all! 🎉

We are thrilled to announce our latest publication on the newly approved drug called "Tofersen" for ALS. This open-access drug chapter will serve as an excellent resource for educating healthcare professionals about this innovative treatment option. #ALS #healthcare #education

@jjlcerillo @NSUResearch Working with you on the newly approved drug for ALS was a wonderful experience. Congratulations on your accomplishment.

🚨FDA approves Elevidys, a gene therapy for kids with DMD. #DMD #Elevidys #genetherapy time.com/6289317/fda-ap…

Warm welcome to our new #BMCPublicHealth Editorial Board Members @stevopo, @parmar399 and @Okeoma_Mmeje. We are looking forward to working with you. Interested in joining #BMCPublicHealth? To find out more visit <bmcpublichealth.biomedcentral.com/about/editoria…>

May is CurePSP Month of Awareness.